Expertise in
2
conditions

Jos A. Stigt

Zwolle, OV, NL 
Expertise in
2
conditions
Zwolle, OV, NL 

Overview

Jos Stigt practices practicing medicine in Zwolle, Netherlands.

Mr. Stigt is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Respiratory Acidosis.

He is actively involved in clinical research, co-authoring 35 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Zwolle, OV, Netherlands
Other Locations
Bosch, NB, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Chemotherapy in KRAS Mutated Chemotherapy Naive Non-small Cell Lung Cancer Patients: a Phase III Study Comparing Cisplatin-pemetrexed With Carboplatin-paclitaxel-bevacizumab: NVALT 22
Chemotherapy in KRAS Mutated Chemotherapy Naive Non-small Cell Lung Cancer Patients: a Phase III Study Comparing Cisplatin-pemetrexed With Carboplatin-paclitaxel-bevacizumab: NVALT 22
Enrollment Status: Unknown
Publish Date: December 21, 2021
Intervention Type: Drug
Study Drugs: Carboplatin, Paclitaxel, Bevacizumab, Pemetrexed, Cisplatin
Study Phase: Phase 3
A Randomized Phase II Study of Erlotinib Compared to Single Agent Chemotherapy-erlotinib Combination in Pretreated Patients With Advanced NSCLC (NVALT10 Study)
A Randomized Phase II Study of Erlotinib Compared to Single Agent Chemotherapy-erlotinib Combination in Pretreated Patients With Advanced NSCLC (NVALT10 Study)
Enrollment Status: Completed
Publish Date: September 29, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Randomized Phase II Study of Paclitaxel-carboplatin-bevacizumab With or Without Nitroglycerin Patches in Patients With Stage IV Non-squamous-non-small Cell Lung Cancer: NVALT12
A Randomized Phase II Study of Paclitaxel-carboplatin-bevacizumab With or Without Nitroglycerin Patches in Patients With Stage IV Non-squamous-non-small Cell Lung Cancer: NVALT12
Enrollment Status: Completed
Publish Date: September 28, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

35 Total Publications

Diaphragm ultrasound and surface electromyography as predictors of clinical deterioration in acute exacerbations of COPD: a prospective observational study.
Diaphragm ultrasound and surface electromyography as predictors of clinical deterioration in acute exacerbations of COPD: a prospective observational study.
Journal: ERJ open research
Published: August 13, 2025

Frequently Asked Questions about Jos A. Stigt

Is Jos A. Stigt a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Jos A. Stigt is classified as an Advanced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jos A. Stigt participate in research or clinical trials?

Yes. Jos A. Stigt has published 35 articles and abstracts on conditions like Lung Cancer. You can view a list of Jos A. Stigt's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Stigt's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile